Skip to main content
. 2018 Apr 18;9:1532. doi: 10.1038/s41467-018-03915-4

Fig. 6.

Fig. 6

Cross-vaccination of 4T1 and EMT6 tumor xenografts by autologous or allogeneic cancer vaccines. a Cross-vaccination experimental design. b, c Distant tumor growth curves and tumor-free percentages of the distant EMT6 tumor-bearing BALB/c mice model. The mean tumor volumes were analysed using one-way ANOVA. ***p < 0.01. Data represent mean ± s.d. (n = 6). d, e Distant tumor growth curves and tumor-free percentages of the distant 4T1 tumor-bearing BALB/c mice. The mean tumor volumes were analysed using one-way ANOVA. ***p < 0.01. Data represent mean ± s.d. (n = 6). f Representative flow cytometry plots showing the proportions of tumor-infiltrating CTLs in distant EMT6 or 4T1 tumors. Data represent mean ± s.d. (n = 3). g Tumor mass-normalized intratumoral infiltration of CD8+ T cells in distant EMT6 or 4T1 tumors. h, i Vaccination-induced secretion of tumor specific IFN-γ by the h peripheral blood mononuclear lymphocytes (PMBCs), and i the spleen lymphocytes, respectively. gi Unpaired student’s t-test (two-tailed) was used for the comparison between two groups. ***p < 0.01. Data represent mean ± s.d. (n = 3)